DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993 – Medical Technology Enterprise
Consortium
Notice is hereby given that, on April 2, 2024,
pursuant to section 6(a) of the National Cooperative
Research and Production Act of 1993, 15 U.S.C. 4301 et seq.
(“the Act”), Medical Technology Enterprise Consortium
(“MTEC”), has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission
disclosing changes in its membership. The notifications
were filed for the purpose of extending the Act’s
provisions limiting the recovery of antitrust plaintiffs to
actual damages under specified circumstances.
Specifically, 10x National Security, Aldie, VA; 4WEB, Inc.,
Frisco, TX; Abram Scientific, Inc., South San Francisco,
CA; Admetsys Corp., Boston, MA; Advanced RNA Vaccine
Technologies, Inc., North Bethesda, MD; Aergility Corp.,
Dunnellon, FL; Airway Shield S.L., Santander Cantabria,
Spain; AmacaThera, Inc., Toronto, CANADA; Ampel LLC,
Charlottesville, VA; Anthos Group, Inc., Torrance, CA; Apos
US Management, Inc., New York, NY; Asynchealth, Pebble
Beach, CA; Baebies, Inc., Durham, NC; Best Practice
Associates LLC dba Tria Federal, Arlington, VA; Bio-Change,
Ltd., Yokneam, ISRAEL; Black Fur Biomedical, Tucson, AZ;

Blue Spark Technologies, Inc., Westlake, OH; Board of
Regents, Nevada System of Higher Education on behalf of the
University of Nevada, Las Vegas, Las Vegas, NV; Board of
the Trustees of the Colorado School of Mines, Golden, CO;
Cadet NM, Inc., Albuquerque, NM; Cambridge Research &
Development, Inc., Nashua, NH; Canaery, Alachua, FL;
Coldplasmatech GmbH, Greifswald, GERMANY; ComeBack
Mobility, Inc., New York, NY; CoolSpine LLC, Woodbury, CT;
Cristae Consulting LLC, Moorestown, NJ; Directed Systems,
Ltd., Cambridge, UNITED KINGDOM; Eluciderm, Inc., San
Diego, CA; ExThera Medical Corp., Martinez, CA; EyeYon
Medical, Ltd., Ness Ziona, ISRAEL; Florida Institute of
Technology, Melbourne, FL; FluidForm, Inc., Waltham, MA;
Gigantor Technologies, Inc., Melbourne Beach, FL; Global
Virtual Training LLC, New York, NY; GoodCap
Pharmaceuticals, Toronto, CANADA; Hatch Product Development
LLC, Waukegan, IL; Henley Ion LLC, New Orleans, LA; Idea
Meds, Inc., New York, NY; Immense Dynamics, Inc.,
Bremerton, WA; Innovative Health Sciences LLC, Chester, NY;
Innovosens AB, Inc., Wilmington, DE; Interoperability
Institute LLC, Lansing, MI; JustBard Technologies LLC,
Brunswick, MD; KaloCyte, Inc., Baltimore, MD; LaCire LLC,
Alexandria, VA; Lankenau Institute for Medical Research,
Wynnewood, PA; Loma Linda University, Loma Linda, CA; Lucid
Reality Labs LLC, Miami, FL; LumaFlo, Inc., Detroit, MI;
Lundquist Institute for Medical Innovation at Harbor-UCLA

Medical Center, Torrance, CA; Medasense Biometrics, Ltd.,
Ramat Gan, ISRAEL; MediCarbone, Inc., Tuscon, AZ; Mitochon
Pharmaceuticals, Inc., Blue Bell, PA; Modular Matter, Inc.,
Abingdon, MD; Moonrise Medical, Inc., Oakville, CANADA;
Noleus Technologies, Inc., Houston, TX; Nou Systems, Inc.,
Huntsville, AL; Noxy Health Products, Inc., Anaconda, MT;
Oak Grove Technologies, Raleigh, NC; Obsidian Solutions
Group, Fredericksburg, VA; Omniox, Inc., San Francisco, CA;
Osetomics LLC, Glen Mills, PA; Osteolyse, Inc., Soda
Springs, CA; Owl Therapeutics, San Antonio, TX; PathKeeper
Surgical, Ltd., Kfar Saba, ISRAEL; PyrAmes, Inc.,
Cupertino, CA; Qidni Labs, Inc., Buffalo, NY; Rafa
Laboratories, Ltd., Jerusalem, ISRAEL; ReBlood Rx LLC, San
Diego, CA; Regerna Therapeutics, Inc., New York, NY;
Regulatory Quality Management Information Source, Inc.,
Amesbury, MA; Remedor Biomed Ltd., Nof Hagalil, ISRAEL;
Renovera, PBC, West Lafayette, IN; Respair, Inc.,
Pittsburgh, PA; RevBio, Inc., Lowell, MA; Rion, Inc.,
Rochester, MN; Saforax Health, Haifa, ISRAEL; SCHOTT North
America New Ventures, Duryea, PA; SenseVOC LLC, Littleton,
CO; Serda B.V., Amsterdam, THE NETHERLANDS; SMSbiotech,
Inc., San Marcos, CA; Stanford University, Stanford, CA;
STEER Tech LLC, Annapolis Junction, MD; Synapstim Ltd.,
Herzliya, ISRAEL; Temple University - Of The Commonwealth
System of Higher Education, Philadelphia, PA; The Hospital
for Special Surgery Fund, Inc., New York, NY; The Institute

for Integrative and Innovative Research at the University
of Arkansas, Fayetteville, Fayetteville, AK; Tietronix
Software, Inc., Houston, TX; TYBR Health, Inc., Houston,
TX; Unit Medical Devices, Ltd., Sderot, ISRAEL; University
of Arkansas, Little Rock, Little Rock, AR; University of
Cincinnati, Cincinnati, OH; Valiant Harbor International
LLC, Bethesda, MD; Vasomune Therapeutics US, Inc., Raleigh,
NC; Velico Medical, Inc., Beverly, MA; ViBo Health, Inc.,
Los Angeles, CA; Videra Health, Inc., Orem, UT; Vir
Biotechnology, San Francisco, CA; ViyaMD, Inc., Marina del
Rey, CA; Western Michigan University Homer Stryker M.D.
School of Medicine, Kalamazoo, MI; and XO Armor
Technologies, Inc., Auburn, AL have been added as parties
to this venture.
Also, 2C4 Technologies, Inc., San Antonio, TX; AbViro
LLC, Bethesda, MD;

Acer Therapeutics, Inc., Newton, MA;

Advanced Surgical Retractor Systems, Inc., Shavano Park,
TX; Allied Technologies and Consulting LLC, Frederick, MD;
Amend Surgical, Inc., Alachua, FL; American Military
Families Action Network, Tacoma, WA; American Type Culture
Collection, Manassas, VA; AMK Technologies of Ohio LLC,
Mount Vernon, OH; Anchor Therapy Clinic, Sacramento, CA;
Applied Research Center, Aiken, SC; Arcascope, Inc.,
Arlington, VA; Aruna Bio, Inc., Athens, GA; Asante Bio,
Tampa, FL; Atorvia Health Technologies, Inc., Ottawa,
Ontario, CANADA; Avel eCare LLC, Sioux Falls , SD;

Axioforce, Inc., St. Louis, MO;
Carlos, CA;

Bio1 Systems, Inc., San

BioAge Labs, Inc., Richmond, CA; Biobeat

Technologies, Ltd., Petach Tikva, ISRAEL; Bionet Sonar,
Inc., Burlington, MA; BiotechPharma Corp., Severna Park,
MD; Board of Trustees of the University of Illinois,
Champaign, IL; Bodies Done Right, Mayfield Village, OH;
California Service Dog Academy, Visalia, CA; Capital
Factory Properties LLC, Austin, TX; Channel Clinical
Solutions LLC, Raleigh, NC; Children's Hospital Los
Angeles, Los Angeles, CA; ClearCoast USA LLC, St.
Petersburg, FL; Concurrent Technologies Corp., Johnstown,
PA; Conseqta Technology, Arlington, VA; Continuous
Precision Medicine, Research Triangle Park, NC; CSP
Technologies, Inc., Auburn, AL; CTD Group LLC, Vashon, WA;
Daxor Corp., Oak Ridge, TN; Decisive Point Group, Beacon,
NY; DermiSense, Inc., Richmond, VA; DHR Health Institute
for Research and Development, Edinburg, TX; Dog Tag
Buddies, Billings, MT; D-Prime LLC, McLean, VA; Drexel
University, Philadelphia, PA; Eagle Global Scientific LLC,
San Antonio, TX; Endoluxe, Inc., Dunwoody, GA; Endomedix,
Inc., Montclair, NJ; Engineering & Computer Simulations,
Inc., Orlando, FL; Entasis Therapeutics, Waltham, MA;
FireFlare Games LLC, Cheyenne, WY; Float Lab Technologies,
Inc., Venice, CA; Foothold Labs, Inc., Olathe, KS; Gel4Med,
Lowell, MA; GelMEDIX, Inc., Newton, MA; GelSana
Therapeutics, Inc., Aurora, CO; Global Resonance

Technologies LLC, Shelburne, VT; Grand Valley State
University, Grand Rapids, MI; Hafion, Inc., Ann Arbor, MI;
Hope 4 You Global LLC, Lowell, AR; Hubly, Inc. dba Hubly
Surgical, Evanston, IL; Human Systems Integration, Inc.
East Walpole, MA; Icahn School of Medicine at Mount Sinai,
New York, NY; ICON Government and Public Health Solutions,
Hinckley, OH; Idion, Inc., Darien, CT; iFyber LLC, Ithaca,
NY; Incell Corp. LLC, San Antonio, TX; IOTAI, Inc.,
Fremont, CA; Jana Care, Inc., Watertown, MA; JC3 LLC,
Rockbridge Baths, VA; Joint Research and Development, Inc.,
Stafford, VA; Jurata Thin Film, Inc., Chapel Hill, NC; K9s
for Warriors, Ponte Vedra Beach, FL; KBR, Beavercreek, OH;
Kerecis, Ltd., Isafjordur, ICELAND; Longhorn Vaccines and
Diagnostics LLC, Bethesda, MD; Lynntech, Inc., College
Station, TX; Manzanita Pharmaceuticals, Inc., Woodside, CA;
Maravai Life Sciences, San Diego, CA; MCPC, Cleveland, OH;
Mechano Therapeutics LLC, Philadelphia, PA; MediView XR,
Inc., Cleveland, OH; Medtronic, Minneapolis, MN; MeMed US,
Inc., Milpitas, CA; Methodist Hospital Research Institute
dba Houston Methodist Research Institute, Houston, TX;
Microbion Corp., Bozeman, MT; Milestone Scientific, Inc.,
Roseland, NJ; MiMedx Group, Inc., Marietta, GA; Muscle
Activation Techniques, Englewood, CO; MVK Pharmaceuticals
LLC, Indianapolis, IN; My Buddies Place, Inc., Pasadena,
CA; Nakamir, Inc. , Palo Alto, CA; Neurotrauma Sciences
LLC, Alpharetta, GA; New York University School of

Medicine, New York, NY; nFlux, Inc., Palm Springs, CA;
NightHawk Biosciences, Inc., Morrisville, NC; Nihon Kohden
OrangeMed, Inc., Santa Ana, CA; North Carolina
Biotechnology Center, Research Triangle Park, NC;
NovoPedics, Inc., Princeton, NJ; Nyrada, Inc., Gordon,
AUSTRALIA; Odic, Inc., Littleton, MA; Omnicure, Inc.,
Ladue, MO; Oregon Biomedical Engineering Institute, Inc.,
Wilsonville, OR; OrganaBio LLC, South Miami, FL;
Orthoforge, Inc., East Grand Rapids, MI; Otter Cove
Solutions LLC, Gaithersburg, MD; Pacific Institute for
Research and Evaluation, Beltsville, MD; Padagis US LLC,
Allegan, MI; Palantir USG, Inc., Palo Alto, CA; PathoGene,
Inc., Monrovia, CA; Paxauris LLC, Phoenix, AZ; Phagelux,
Inc., Montréal, CANADA; Philips North America LLC,
Cambridge, MA; Population Sleep LLC, Dallas, TX;
PortaVision Medical LLC, Jefferson, LA; ppx-TEC LLC,
Jackson, MS; Precision Trauma LLC, Columbus, GA;

Problem

Solutions LLC, Johnstown, PA; Prohuman Technologies,
Concord, NC; Promethean LifeSciences, Inc., Pittsburgh, PA;
Purdue University, West Lafayette, IN; Red One Medical
Devices LLC,Savannah, GA; Regenerative Processing Plant
LLC, Tampa, FL; Regranion LLC, Mt. Pleasant, SC; Renerva
LLC, Pittsburgh, PA; Resilient Lifescience, Inc.,
Pittsburgh, PA; Reveille Group, Tampa, FL; Rock West
Composites, Inc., San Diego, CA; RST-Sanexas, Las Vegas,
NV; SafeBeat Rx, Inc., Chico, CA; SafeBVM Corp., Boston,

MA; Safeguard Surgical, Tampa, FL; Safi Biotherapeutics,
Inc., Cambridge, MA; Saint Barnabas Medical Center,
Livingston, NJ; Saint Louis University, St. Louis, MO;
Sanofi Pasteur, Swiftwater, PA; Scientific & Biomedical
Microsystems LLC, Glen Burnie, MD; SeaStar Medical, Inc.,
Denver, CO; Securisyn Medical LLC, Highlands Ranch, CO;
Senseye, Inc., Austin, TX; Shee Atiká Enterprises,
Huntsville, AL; Sherpa 6, Inc., Littleton, CO; Shipcom
Federal Solutions LLC, Belcamp, MD; SLSCO, Ltd., Galveston,
TX; Softox Solutions AS, Fornebu, Norway Soliyarn, Belmont,
MA; Sophic Synergistics LLC, Houston, TX; Sparta
Biomedical, Inc., Chatham, NJ; SPEAR Human Performance,
Inc., Sandy Springs, GA; SpineThera, Inc., Plymouth, MN;
Steadman Philippon Research Institute, Vail, CO;
Stellarray, Inc., Austin, TX; Sterogene Bioseparations,
Inc., Carlsbad, CA; TechEn, Inc., Milford, MA; Terasaki
Institute for Biomedical Innovation, Los Angeles, CA; Texas
A&M University, College Station, TX; Texas Research &
Technology Foundation, San Antonio, TX; The Emmes Company
LLC, Rockville, MD; The Research Institute of the McGill
University Health Centre, Montreal, CANADA; TiER1
Performance Solutions, Covington, KY;

Transom Scopes, Inc.

dba Instrument Technology, Inc., Westfield, MA;

Trustees

of the University of Pennsylvania, Philadelphia, PA; UCHU
Biosensors, Inc., Newark, NJ; University of Miami, Coral
Gables, FL; University of Southern California, Los Angeles,

CA; U-Smell-It LLC, Guilford, CT;

Vaxxas, Cambridge, MA;

Viele Exploratory Sustainable Solutions LLC, Livingston
Manor, NY; Virion Therapeutics LLC, Newark, DE; Weinberg
Medical Physics, Inc., North Bethesda, MD;

Westat, Inc.,

Rockville, MD; Xheme, Inc., Newton, MA; Xomix, Ltd.,
Chicago, IL; and ZeSa LLC, Eden Prarie, MN have withdrawn
as parties to this venture.
No other changes have been made in either the
membership or planned activity of the group research
project.

Membership in this group research project remains

open, and MTEC intends to file additional written
notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification
pursuant to section 6(a) of the Act.

The Department of

Justice published a notice in the Federal Register pursuant
to section 6(b) of the Act on June 9, 2014 (79 FR 32999).
The last notification was filed with the Department on
January 9, 2024. A notice was published in the Federal
Register pursuant to section 6(b) of the Act on February 6,
2024 (89 FR 8246).
Suzanne Morris,
Deputy Director Civil Enforcement Operations,
Antitrust Division.
[FR Doc. 2024-13611 Filed: 6/20/2024 8:45 am; Publication Date: 6/21/2024]